Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × abemaciclib × Clear all

Sponsor

Conditions

Breast Neoplasms 21 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Neoplasms 3 Sarcoma, Ewing 2 Glioblastoma 2 Brain Neoplasms 2 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Castration-Resistant Prostate Cancer 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Hormone Receptor Positive Breast Cancer 1 Glioma 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡